Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meijerink

Showing results (591-600 of 749) with videos related to

Pageof 75
Sort By:
NPJ Digital Medicine|July 11, 2024
Digital biomarkers for non-motor symptoms in Parkinson's disease: the state of the artJules M Janssen Daalen, Robin van den Bergh, Eva M Prins, et al.
British Journal of Cancer|December 8, 2005
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemiaI Hubeek, R W Stam, G J Peters, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trialBart Geboers, Florentine Timmer, Danielle Vos, et al.
Cancer Cell|August 15, 2018
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic LeukemiaMarlies Vanden Bempt, Sofie Demeyer, Michaël Broux, et al.
Leukemia|April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemiaKimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
The Journal of Sexual Medicine|September 3, 2008
Psychophysiological assessment of sexual function in women after radiotherapy and total mesorectal excision for rectal cancer: a pilot study on four patientsStephanie O Breukink, Jan C Wouda, Marieke J Van Der Werf-Eldering, et al.
Nature Genetics|May 18, 2010
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Idoya Lahortiga, Tiama El Chaar, et al.
Neurology|September 1, 1996
Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth diseaseA A Gabreëls-Festen, J E Hoogendijk, P H Meijerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2015
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic CancerAnnette A van Zweeden, Hans J van der Vliet, Johanna W Wilmink, et al.
Pageof 75

Showing results (591-600 of 749) with videos related to

Sort By:
Pageof 75
NPJ Digital Medicine|July 11, 2024
Digital biomarkers for non-motor symptoms in Parkinson's disease: the state of the artJules M Janssen Daalen, Robin van den Bergh, Eva M Prins, et al.
British Journal of Cancer|December 8, 2005
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemiaI Hubeek, R W Stam, G J Peters, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trialBart Geboers, Florentine Timmer, Danielle Vos, et al.
Cancer Cell|August 15, 2018
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic LeukemiaMarlies Vanden Bempt, Sofie Demeyer, Michaël Broux, et al.
Leukemia|April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemiaKimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
The Journal of Sexual Medicine|September 3, 2008
Psychophysiological assessment of sexual function in women after radiotherapy and total mesorectal excision for rectal cancer: a pilot study on four patientsStephanie O Breukink, Jan C Wouda, Marieke J Van Der Werf-Eldering, et al.
Nature Genetics|May 18, 2010
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Idoya Lahortiga, Tiama El Chaar, et al.
Neurology|September 1, 1996
Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth diseaseA A Gabreëls-Festen, J E Hoogendijk, P H Meijerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2015
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic CancerAnnette A van Zweeden, Hans J van der Vliet, Johanna W Wilmink, et al.
Pageof 75